Hudson Therapeutics announced that Shaperon (KOSDAQ 378800, CEO Seung-Yong Seong), an innovative biopharmaceutical company specializing in immune therapeutics, has signed a Memorandum of Understanding (MOU) with Dong-A ST (KOSPI 170900, CEO Min-Young.
Shaperon & Hudson to Participate in the 2024 Bio International Convention tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
RESEARCH TRIANGLE PARK, N.C. (BUSINESS WIRE) Hudson Therapeutics, Inc., a biotechnology company specializing in anti-inflammatory and immuno-oncology drugs, announced that Janice Marie McCourt has been appointed to co-Chief Executive Officer and a member of the Hudson Board of Directors, effective October 30, 2023.